405 related articles for article (PubMed ID: 12215555)
1. Limited sensitivity of parathyroid imaging with (99m)Tc-sestamibi/(123)I subtraction in an endemic goiter area.
Rink T; Schroth HJ; Holle LH; Garth H
J Nucl Med; 2002 Sep; 43(9):1175-80. PubMed ID: 12215555
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy.
Nguyen BD
Radiographics; 1999; 19(3):601-14; discussion 615-6. PubMed ID: 10336191
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123.
Hindié E; Mellière D; Jeanguillaume C; Perlemuter L; Chéhadé F; Galle P
J Nucl Med; 1998 Jun; 39(6):1100-5. PubMed ID: 9627353
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
[TBL] [Abstract][Full Text] [Related]
6. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
7. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
9. Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions.
Mazzeo S; Caramella D; Lencioni R; Molea N; De Liperi A; Marcocci C; Miccoli P; Iacconi P; Bossio GB; Viacava P; Lazzeri E; Bartolozzi C
AJR Am J Roentgenol; 1996 Jun; 166(6):1465-70. PubMed ID: 8633466
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
Leslie WD; Dupont JO; Bybel B; Riese KT
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
[TBL] [Abstract][Full Text] [Related]
11. Tc-99m sestamibi parathyroid gland scintigraphy: added value of Tc-99m pertechnetate thyroid imaging for increasing interpretation confidence and avoiding additional testing.
Powell DK; Nwoke F; Goldfarb RC; Ongseng F
Clin Imaging; 2013; 37(3):475-9. PubMed ID: 23102932
[TBL] [Abstract][Full Text] [Related]
12. Preoperative technetium Tc 99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter.
Lorberboym M; Ezri T; Schachter PP
Arch Surg; 2005 Jul; 140(7):656-60. PubMed ID: 16027330
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands.
Wei JP; Burke GJ; Mansberger AR
Surgery; 1992 Dec; 112(6):1111-6; discussion 1116-7. PubMed ID: 1455313
[TBL] [Abstract][Full Text] [Related]
14. Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism.
Blanco I; Carril JM; Banzo I; Quirce R; Gutierrez C; Uriarte I; Montero A; Vallina NK
Clin Nucl Med; 1998 May; 23(5):291-7. PubMed ID: 9596153
[TBL] [Abstract][Full Text] [Related]
15. Primary hyperparathyroidism: is technetium 99m-Sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery?
Hindié E; Melliere D; Simon D; Perlemuter L; Galle P
J Clin Endocrinol Metab; 1995 Jan; 80(1):302-7. PubMed ID: 7829631
[TBL] [Abstract][Full Text] [Related]
16. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
[TBL] [Abstract][Full Text] [Related]
17. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism.
Casas AT; Burke GJ; Mansberger AR; Wei JP
Am Surg; 1994 Jan; 60(1):12-6; discussion 16-7. PubMed ID: 8273968
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
19. Preoperative localization and radioguided parathyroid surgery.
Mariani G; Gulec SA; Rubello D; Boni G; Puccini M; Pelizzo MR; Manca G; Casara D; Sotti G; Erba P; Volterrani D; Giuliano AE
J Nucl Med; 2003 Sep; 44(9):1443-58. PubMed ID: 12960191
[TBL] [Abstract][Full Text] [Related]
20. Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands.
Giordano A; Marozzi P; Meduri G; Ficola U; Calcagni ML; Vaccaro A; Rubini G; Attard M; Li Puma M; Ricci R; Corsello S
Eur J Nucl Med; 1999 Aug; 26(8):907-11. PubMed ID: 10436206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
